(a)The board shall provide for an
ephedrine, pseudoephedrine, and controlled substance prescription
monitoring program that includes the following components:
(1)Each time ephedrine, pseudoephedrine, or a controlled
substance designated by the board under IC 35-48-2-5 through IC 35-48-2-10 is dispensed, the dispenser shall transmit to the
INSPECT program the following information:
(A)The ephedrine, pseudoephedrine, or controlled substance
recipient's name.
(B)The ephedrine, pseudoephedrine, or controlled substance
recipient's or the recipient representative's identification
number or the identification number or phrase designated by
the INSPECT program.
(C)The ephedrine, pseudoephedrine, or controlled substance
recipient's date of birth.
(D)The national drug code number of the ephedr
Free access — add to your briefcase to read the full text and ask questions with AI
(a) The board shall provide for an
ephedrine, pseudoephedrine, and controlled substance prescription
monitoring program that includes the following components:
(1) Each time ephedrine, pseudoephedrine, or a controlled
substance designated by the board under IC 35-48-2-5 through IC 35-48-2-10 is dispensed, the dispenser shall transmit to the
INSPECT program the following information:
(A) The ephedrine, pseudoephedrine, or controlled substance
recipient's name.
(B) The ephedrine, pseudoephedrine, or controlled substance
recipient's or the recipient representative's identification
number or the identification number or phrase designated by
the INSPECT program.
(C) The ephedrine, pseudoephedrine, or controlled substance
recipient's date of birth.
(D) The national drug code number of the ephedrine,
pseudoephedrine, or controlled substance dispensed.
(E) The date the ephedrine, pseudoephedrine, or controlled
substance is dispensed.
(F) The quantity of the ephedrine, pseudoephedrine, or
controlled substance dispensed.
(G) The number of days of supply dispensed.
(H) The dispenser's United States Drug Enforcement Agency
registration number.
(I) The prescriber's United States Drug Enforcement Agency
registration number.
(J) An indication as to whether the prescription was transmitted
to the pharmacist orally or in writing.
(K) Other data required by the board.
(2) The information required to be transmitted under this section
must be transmitted not more than twenty-four (24) hours after the
date on which ephedrine, pseudoephedrine, or a controlled
substance is dispensed. However, if the dispenser's pharmacy is
closed the day following the dispensing, the information must be
transmitted by the end of the next business day. A dispenser who
is also authorized to prescribe is required only to report actual
dispensations within twenty-four (24) hours of the dispensation.
(3) A dispenser shall transmit the information required under this
section by:
(A) uploading to the INSPECT Internet web site; or
(B) another electronic method that meets specifications
prescribed by the board.
(4) The board may require that prescriptions for ephedrine,
pseudoephedrine, or controlled substances be written on a one (1)
part form that cannot be duplicated. However, the board may not
apply such a requirement to prescriptions filled at a pharmacy
with a Category II permit (as described in IC 25-26-13-17) and
operated by a hospital licensed under IC 16-21, or prescriptions
ordered for and dispensed to bona fide enrolled patients in
facilities licensed under IC 16-28. The board may not require
multiple copy prescription forms for any prescriptions written.
The board may not require different prescription forms for any
individual drug or group of drugs. Prescription forms required
under this subdivision must be approved by the Indiana board of
pharmacy created by IC 25-26-13-3.
(5) The costs of the program.
(6) As part of the information to be completed in the data base
and, if available, an entry where a dispenser indicates that a
patient is participating in a pain management contract with a
designated practitioner.
(b) The board shall consider the recommendations of the committee
concerning the INSPECT program.
(c) This subsection applies only to a retail pharmacy. A pharmacist,
pharmacy technician, or person authorized by a pharmacist to dispense
ephedrine, pseudoephedrine, or a controlled substance may not
dispense ephedrine, pseudoephedrine, or a controlled substance to a
person who is not personally known to the pharmacist, pharmacy
technician, or person authorized by a pharmacist to dispense a
controlled substance unless the person taking possession of the
ephedrine, pseudoephedrine, or controlled substance provides
documented proof of the person's identification to the pharmacist,
pharmacy technician, or person authorized by a pharmacist to dispense
ephedrine, pseudoephedrine, or a controlled substance.